Open access
Open access
Powered by Google Translator Translator

Gastroenterology (all articles)

Review | Fatigue in cirrhosis.

21 Jul, 2022 | 12:52h | UTC

Fatigue in Cirrhosis – Journal of Clinical and Experimental Hepatology

 


Review | Therapeutic advances in alcohol-associated hepatitis.

21 Jul, 2022 | 12:36h | UTC

Therapeutic advances in alcohol-associated hepatitis – Journal of Hepatology

Related: Liver Transplantation in Alcohol-related Liver Disease and Alcohol-related Hepatitis – Journal of Clinical and Experimental Hepatology

 

Commentary on Twitter

 


EASL Clinical Practice Guidelines on the management of cystic liver diseases.

19 Jul, 2022 | 13:34h | UTC

EASL Clinical Practice Guidelines on the management of cystic liver diseases – Journal of Hepatology

 

Commentary on Twitter

 


EASL Clinical Practice Guidelines on sclerosing cholangitis.

19 Jul, 2022 | 13:36h | UTC

EASL Clinical Practice Guidelines on sclerosing cholangitis – Journal of Hepatology

 

Commentary on Twitter

 


Review and Clinical Guidance | Respiratory events with Terlipressin and albumin in hepatorenal syndrome.

19 Jul, 2022 | 13:32h | UTC

Respiratory Events With Terlipressin and Albumin in Hepatorenal Syndrome: A Review and Clinical Guidance – Liver International

 


EASL Clinical Practice Guidelines on hemochromatosis.

18 Jul, 2022 | 11:47h | UTC

EASL Clinical Practice Guidelines on haemochromatosis – Journal of Hepatology

 


EASL Clinical Practice Guidelines on the management of hepatic encephalopathy.

18 Jul, 2022 | 11:49h | UTC

EASL Clinical Practice Guidelines on the management of hepatic encephalopathy – Journal of Hepatology

 

Commentary on Twitter

 


M-A of RCTs | Efficacy and safety of potassium-competitive acid blockers versus proton pump inhibitors as Helicobacter pylori eradication therapy.

18 Jul, 2022 | 11:03h | UTC

Efficacy and safety of potassium-competitive acid blockers versus proton pump inhibitors as Helicobacter pylori eradication therapy: a meta-analysis of randomized clinical trials – Clinics

 


Cystic liver lesions: a pictorial review.

18 Jul, 2022 | 10:48h | UTC

Cystic liver lesions: a pictorial review – Insights into Imaging

 


Pediatric intestinal pseudo-obstruction: progress and challenges.

15 Jul, 2022 | 12:24h | UTC

Pediatric Intestinal Pseudo-Obstruction: Progress and Challenges – Frontiers in Pediatrics

 


WHO Updated Report | Severe acute hepatitis of unknown etiology in children.

14 Jul, 2022 | 12:54h | UTC

Severe acute hepatitis of unknown aetiology in children – Multi-country – World Health Organization

Related:

Indeterminate pediatric acute liver failure: Clinical characteristics of a temporal cluster of five children in the Netherlands in the spring of 2022 – UEG Journal

Sudden onset hepatitis in children – Nature Reviews Gastroenterology & Hepatology (if the link is paywalled, try this one)

Outbreak of hepatitis in children: clinical course of children with acute liver failure admitted to the intensive care unit – Intensive Care Medicine (if the link is paywalled, try this one)

Investigating Acute Hepatitis of Unknown Origin in Children – American Society for Microbiology

What’s sending kids to hospitals with hepatitis—coronavirus, adenovirus, or both? – Science

Investigation into acute hepatitis of unknown aetiology in children in England Technical briefing 3 – UK Health Security Agency

Case numbers of acute hepatitis of unknown aetiology among children in 24 countries up to 18 April 2022 compared to the previous 5 years – Eurosurveillance

Severe acute hepatitis and acute liver failure of unknown origin in children: a questionnaire-based study within 34 paediatric liver centres in 22 European countries and Israel, April 2022 – Eurosurveillance

Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens – The Lancet Gastroenterology & Hepatology

Puzzling pediatric hepatitis cases echo an earlier mysterious illness – STAT

Why COVID is a key suspect in severe hepatitis cases in kids worldwide – CBC

Hepatitis outbreak in children: What do we know so far? – Imperial College London

Explaining the unexplained hepatitis in children – The Lancet Infectious Diseases

Epidemiological update: Hepatitis of unknown aetiology in children – European Centre for Disease Prevention and Control

Unexplained hepatitis cases in kids rise to 348 in 20 nations – CIDRAP

Investigation into acute hepatitis of unknown aetiology in children in England Technical briefing 2 – UK Health Security Agency

With usual suspects ruled out, disease detectives try to crack mystery of viral hepatitis cases in kids – STAT

Acute Hepatitis and Adenovirus Infection Among Children — Alabama, October 2021–February 2022 – Morbidity and Mortality Weekly Report

The CDC and WHO Have Reported an Unusual Cluster of Severe Pediatric Hepatitis Cases – Science-Based Medicine

Investigation into acute hepatitis of unknown aetiology in children in England Technical briefing – UK Health Security Agency

Multi-Country – Acute, severe hepatitis of unknown origin in children – World Health Organization

WHO says 12 countries have reported unusual cases of hepatitis in kids – STAT

CDC Alerts Providers to Hepatitis Cases of Unknown Origin – Centers for Disease Control and Prevention

Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology – Centers for Disease Control and Prevention

Could Mysterious Hepatitis Cases be Triggered by COVID-19? – Health Policy Watch

Increase in hepatitis (liver inflammation) cases in children under investigation – UK Health Security Agency

U.S., U.K. investigating unusual cases of hepatitis in young children – STAT

Acute hepatitis of unknown aetiology – the United Kingdom of Great Britain and Northern Ireland – World Health Organization

Increase in acute hepatitis of unknown origin among children – United Kingdom – European Centre for Disease Prevention and Control

Mysterious liver illness seen in kids in US, Europe – Associated Press

 


A case series of children with acute hepatitis and human Adenovirus infection.

14 Jul, 2022 | 12:56h | UTC

A Case Series of Children with Acute Hepatitis and Human Adenovirus Infection – New England Journal of Medicine (link to abstract – $ for full-text)

Related Study: Clinical Spectrum of Children with Acute Hepatitis of Unknown Cause – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Unexplained Acute Hepatitis in Children: More Evidence for Adenovirus 41 — Two studies point to a suspiciously high prevalence – MedPage Today (free registration required)

 

Commentaries on Twitter

 


Cohort Study | Prediction models for celiac disease development in children from high-risk families.

14 Jul, 2022 | 12:31h | UTC

Prediction Models for Celiac Disease Development in Children From High-Risk Families: Data From the PreventCD Cohort – Gastroenterology

 


Randomized crossover trial | AI reduces miss rate of precancerous polyps in colorectal cancer screening.

14 Jul, 2022 | 12:29h | UTC

News Release: AI reduces miss rate of precancerous polyps in colorectal cancer screening – Mayo Clinic

Original Study: Impact of Artificial Intelligence on Miss Rate of Colorectal Neoplasia – Gastroenterology

 


M-A | Risk of developing gallbladder cancer in patients with gallbladder polyps detected on Trans-Abdominal ultrasound.

14 Jul, 2022 | 12:14h | UTC

Risk of developing gallbladder cancer in patients with gallbladder polyps detected on Trans-Abdominal ultrasound: a systematic review and Meta-Analysis – British Journal of Radiology (link to abstract – $ for full-text)

Related:

Critical Analysis of the Updated Guidelines for Management of Gallbladder Polyps – Annals of Surgical Oncology (if the link is paywalled, try this one)

Guideline: Management and follow-up of gallbladder polyps – “If the patient has no risk factors for malignancy, and a gallbladder polypoid lesion of 5 mm or less, follow-up is not required”.

 


M-A | The effect of fiber supplementation on chronic constipation in adults.

13 Jul, 2022 | 11:30h | UTC

The effect of fiber supplementation on chronic constipation in adults: an updated systematic review and meta-analysis of randomized controlled trials – The American Journal of Clinical Nutrition

 


Network M-A | The comparisons of different therapeutic modalities for idiopathic achalasia.

12 Jul, 2022 | 11:58h | UTC

The comparisons of different therapeutic modalities for idiopathic achalasia: A systematic review and network meta-analysis – Medicine

 


Consensus on the management of complications of cirrhosis of the liver in pediatrics.

11 Jul, 2022 | 12:24h | UTC

Consensus on the management of complications of cirrhosis of the liver in pediatrics – Revista de Gastroenterología de México (English Edition)

 


RCT | 20% albumin vs. plasmalyte in patients with cirrhosis and sepsis-induced hypotension.

11 Jul, 2022 | 12:16h | UTC

A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial] – Journal of Hepatology

 


Review | Anorexia nervosa and the gastrointestinal tract.

11 Jul, 2022 | 12:08h | UTC

Anorexia nervosa and the gastrointestinal tract – Frontline Gastroenterology (free for a limited period)

 

Commentaries on Twitter

 


BSG guidelines on the management of functional dyspepsia.

8 Jul, 2022 | 12:03h | UTC

British Society of Gastroenterology guidelines on the management of functional dyspepsia – Gut

Related:

Evidence-based clinical practice guidelines for functional dyspepsia 2021 – Journal of Gastroenterology

United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia – UEG Journal

 


Review | Gallstone disease in cirrhosis – Pathogenesis and management.

7 Jul, 2022 | 12:21h | UTC

Gallstone Disease in Cirrhosis—Pathogenesis and Management – Journal of Clinical and Experimental Hepatology

 


Review | Tuberculosis in cirrhosis – A diagnostic and management conundrum.

7 Jul, 2022 | 12:18h | UTC

Tuberculosis in Cirrhosis – A Diagnostic and Management Conundrum – Journal of Clinical and Experimental Hepatology

 


RCT | Odevixibat treatment in progressive familial intrahepatic cholestasis.

6 Jul, 2022 | 11:35h | UTC

Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial – The Lancet Gastroenterology & Hepatology

Invited Commentary: The first new drug for progressive familial intrahepatic cholestasis – The Lancet Gastroenterology & Hepatology (free registration required)

 

Commentary on Twitter


RCT | Enterosgel (polymethylsiloxane polyhydrate) for the treatment of irritable bowel syndrome with diarrhea.

6 Jul, 2022 | 11:33h | UTC

Double-blinded randomised placebo controlled trial of enterosgel (polymethylsiloxane polyhydrate) for the treatment of IBS with diarrhoea (IBS-D) – Gut


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.